Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain.

@article{Wu1997ImpactOC,
  title={Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain.},
  author={Alan H. B. Wu and Jonathan Clive},
  journal={Clinical chemistry},
  year={1997},
  volume={43 2},
  pages={326-32}
}
We obtained data on hospital length of stay (LOS) and total laboratory charges for Medicare patients admitted to 82 hospitals in Massachusetts during 1994. Five Diagnosis Related Groups (DRGs) were selected: surviving acute myocardial infarction (AMI) with, and without, complications; AMI with death; angina pectoris; and chest pain. The hospitals were grouped according to their laboratory policies for testing CK-MB (e.g., frequency of assay runs; information obtained by telephone survey). The… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

The costs and effectiveness of a rapid diagnostic and treatment protocol for myocardial infarction

  • FP Anderson, RL Jesse, CS Nicholson, WG. Miller
  • 1996
1 Excerpt

Cardiac troponin T: biochemical, analytical, and clinical aspects

  • Wu AHB
  • J Clin Immunoassay
  • 1994
1 Excerpt

Mandatory laboratory consultation. How one hospital’s program reduced overuse of cardiac tests

  • K Lewandrowski, E Bailey, E Dhanak, M Laposata, J. Flood
  • Lab Med
  • 1994
1 Excerpt

Similar Papers

Loading similar papers…